Sofosbuvir as a drug in recurrent HCV therapy occurring after liver transplantation
Sofosbuvir is a drug, which has been found useful in HCV (Hepatis C Virus) therapy. It replaced the previously used interferon, the applied of which has shown many side effects or lack of response to treatment. The usage of sofosbuvir with ribavirin shortens the time of treatment and minimizes the n...
Main Authors: | Katarzyna Lipa, Magdalena Julia Jabłońska, Patryk Kaczor, Kamil Leis, Krystian Kałużny, Przemysław Gałązka |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2018-09-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5950 |
Similar Items
-
Sofosbuvir as a drug in recurrent HCV therapy occurring after liver transplantation
by: Katarzyna Lipa, et al.
Published: (2018-09-01) -
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
by: Michael Duerr, et al.
Published: (2019-02-01) -
Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience
by: Bandar Al-Judaibi, et al.
Published: (2018-05-01) -
Changes in tryptophan and phenylalanine in chronic HCV patients treated with direct acting antiviral (sofosbuvir)
by: Eman G. Behiry, et al.
Published: (2018-11-01) -
Current nosological status, pathomechanism and treatment of catatonia
by: Magdalena Julia Jabłońska, et al.
Published: (2018-09-01)